The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
New strategies against drug resistance to herpes simplex virus
Open accessAbstract
Herpes simplex virus (HSV), a member of the Herpesviridae family, is a significant human pathogen that results in mucocutaneous lesions in the oral cavity or genital infections. Acyclovir (ACV) and related nucleoside analogues can successfully treat HSV infections, but the emergence of drug resistance to ACV has created a barrier for the treatment of HSV infections, especially in immunocompromised patients. There is an urgent need to explore new and effective tactics to circumvent drug resistance to HSV. This review summarises the current strategies in the development of new targets (the DNA helicase/primase (H/P) complex), new types of molecules (nature products) and new antiviral mechanisms (lethal mutagenesis of Janus-type nucleosides) to fight the drug resistance of HSV. So-called “Janus” drugs with two molecular “faces” may help address the pressing need for new treatments for herpes simplex virus (HSV). The emergence of resistance to common antiviral drugs such as acyclovir is an increasing problem, especially for patients with weakened immune systems. A team led by Yu-Chen Jiang at Sichuan University, and Hui Feng, Central South University, Changsha, review key strategies for new ways to halt the multiplication of HSV. One of the most promising involves drugs that, like acyclovir, mimic the molecular components of DNA and therefore interfere with the manufacture of viral DNA. Two key DNA components are purines and pyrimidines. The Janus drug molecules have one side that mimics purines while the other side mimics pyrimidines, allowing a double-hit against virus multiplication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Cited by
Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform
Sun, S., Jin, L., Zheng, Y., & Zhu, J. (2022) · Nature Communications · doi:10.1038/s41467-022-33114-1 · Cited by 78
Management of Herpes simplex virus epithelial keratitis
Roozbahani, M., & Hammersmith, K. M. (2018) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000483 · Cited by 47
Metadata
- Authors
- Jiang, Y.-C., Feng, H., Lin, Y.-C., & Guo, X.-R.
- Venue
- International Journal of Oral Science
- Published
- 2016-03
- Volume
- 8
- Issue
- 1
- Pages
- 1-6
- ISSN
- 1674-2818 (ISSN-L)
- 2049-3169
- OpenAlex
- W2330073315
- Cited by
- 225
- References
- 1
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New strategies against drug resistance to herpes simplex virus. https://app.cochat.ai/papers/10.1038/ijos.2016.3
- The paper
- Jiang, Y.-C., Feng, H., Lin, Y.-C., & Guo, X.-R. (2016). New strategies against drug resistance to herpes simplex virus. International Journal of Oral Science. https://doi.org/10.1038/ijos.2016.3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.